Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal.

× No keyword cloud information.

19 in total

1. Immune thrombocytopenia: getting back to basics.

Authors: Donald M Arnold
Journal: Am J Hematol Date: 2012-07-05 Impact factor: 10.047

Review 2. Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.

Authors: Bing-Bing Yang; Sameer Doshi; Karen Arkam; Janet Franklin; Andrew T Chow
Journal: Clin Pharmacokinet Date: 2016-09 Impact factor: 6.447

3. Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia.

Authors: James Signorovitch; Andres Brainsky; Kelly M Grotzinger
Journal: Qual Life Res Date: 2011-05-01 Impact factor: 4.147

4. Privigen immune globulin intravenous (human), 10% liquid.

Authors:
Journal: P T Date: 2011-08

5. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.

Authors: David J Kuter; Cynthia Macahilig; Kelly M Grotzinger; Sara A Poston; Peter Feng Wang; Katie L Dawson; Melea Ward
Journal: Int J Hematol Date: 2015-01-14 Impact factor: 2.490

6. [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Authors: Ingrid Pabinger; Günther Gastl; Michael Steurer; Siegfried Sormann; Michael Fillitz; Josef Friedl; Dietmar Geissler; Klaus Geissler; Richard Greil; Paul Knöbl; Sibylle Kozek-Langenecker; Peter Krippl; Paul Kyrle; Alois Lang; Werner Linkesch; Heinz Ludwig; Markus Müller; Simon Panzer; Elisabeth Pittermann; Josef Thaler; Ansgar Weltermann
Journal: Wien Klin Wochenschr Date: 2012-03-03 Impact factor: 1.704

Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal.

1. Immune thrombocytopenia: getting back to basics.

Review 2. Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.

3. Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia.

4. Privigen immune globulin intravenous (human), 10% liquid.

5. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.

6. [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

7. Comorbidities in patients with persistent or chronic immune thrombocytopenia.

8. From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia.

9. Treatment of immune thrombocytopenic purpura: focus on eltrombopag.

10. Comorbidities of idiopathic thrombocytopenic purpura: a population-based study.